Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001274737-24-000009)

Filing Details

Accession Number:: 0001274737-24-000009
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-02-08 16:05:31
Reporting Period:: 2024-02-06

Accepted Time:: 2024-02-08 16:05:31
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1274737	Exagen Inc.	XGN	Services-Medical Laboratories (8071)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1788393	Kamal Adawi	C/O Exagen Inc. 1261 Liberty Way Vista CA 92081	Cfo And Corporate Secretary	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2024-02-06	6,738	$1.95	181,533	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on February 4, 2022.